Financial News · Live Terminal

Page 139 of 171

Truist Downgrades Doximity to Hold From Buy, Cuts Price Target to $29 From $37

Doximity (DOCS) has an average rating of overweight and mean price target of $37.43, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$DOCS

Research20d ago

RBC Downgrades Gitlab to Sector Perform From Outperform, Cuts Price Target to $25 From $33

Gitlab (GTLB) has an average rating of hold and mean price target of $32.08, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$GTLB

Research20d ago

Wells Fargo Upgrades Biogen to Overweight From Equalweight, Adjusts PT to $250 From $200

Biogen (BIIB) has an average rating of overweight and mean price target of $210.96, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BIIB

Research20d ago

Wells Fargo Downgrades NXP Semiconductors to Equalweight From Overweight, Adjusts PT to $235 From $265

NXP Semiconductors NV (NXPI) has an average rating of overweight and mean price target of $259.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NXPI

Research20d ago

Jefferies Downgrades Exelon to Hold From Buy, Adjusts Price Target to $50 From $55

Exelon (EXC) has an average rating of hold and mean price target of $51, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$EXC

Research20d ago

Mizuho Downgrades Skyworks Solutions to Underperform From Neutral, Adjusts PT to $46 From $60

Skyworks Solutions (SWKS) has an average rating of hold and mean price target of $64.06, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SWKS

Research20d ago

Goldman Sachs Upgrades Williams Companies to Buy From Neutral, Adjusts PT to $82 From $78

Williams Companies (WMB) has an average rating of overweight and mean price target of $81.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$WMB

Research20d ago

Jefferies Upgrades Ulta Beauty to Buy From Hold, Adjusts Price Target to $700 From $635

Ulta Beauty (ULTA) has an average rating of overweight and mean price target of $689.67, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ULTA

Research20d ago

Deutsche Bank Upgrades Ecolab to Buy From Hold, Price Target is $325

Ecolab (ECL) has an average rating of overweight and mean price target of $322.11, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$ECL

Research20d ago

Berenberg Upgrades Air Products and Chemicals to Buy From Hold, Adjusts PT to $350 From $275

Air Products and Chemicals (APD) has an average rating of overweight and mean price target of $321.53, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$APD

Research20d ago

Research Alert: CFRA Keeps Buy Recommendation On Adss Of Icici Bank

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our unchanged target price of USD35 is 20.2x our projected earnings per ADS (EPADS) for FY 27 (Mar.), vs. peers HDFC's 15x and SBI's 11.7x, which we think fairly reflects ICICI's resilient earnings and our projected ROE of 15.5%-16% for FY 27/FY 28, vs. HDFC's 14%-15% and SBI's 15%-15.5%. We expect ICICI's domestic loan growth to ease but stay strong at a low-teen level p.a. in FY 27/FY 28 (FY 26: +15%). Business and corporate loans will continue to lead the growth, but retail loan growth should also pick up in FY 27 from the positive impact of the GST reform and the strong housing market. We see some pressure on NIM from the 25-bp repo rate reduction in December and competition, but faster growth in higher-yielding business loans and ICICI's relatively high mix of CASA deposits will keep its NIM above the industry's, while the strengthening of its asset quality will bring down provision charges. We lift our EPADS estimate for FY 27 to INR160.78 from INR158.12, and introduce an FY 28 EPADS of INR175.40.

$IBN

Research20d ago

Phillip Securities Upgrades PTG Energy to Buy from Hold; Price Target is THB10.20

$BKK:PTG

Research20d ago

Emkay Global Starts WPIL at Buy with INR650 Price Target

$BOM:505872$NSE:WPI

Research20d ago

JM Financial Downgrades Angel One to Add from Buy; Price Target is INR350

$BOM:543235$NSE:ANGELONE

Research20d ago

Avendus Spark Starts Radico Khaitan at Buy with INR4,177 Price Target

$BOM:532497$NSE:RADICO

Research20d ago

Krungsri Securities Downgrades Delta Electronics Thailand to Reduce from Neutral, Price Target is THB232

$BKK:DELTA

Research20d ago

Nomura Upgrades Anji Microelectronics Technology to Buy From Neutral, Adjusts Price Target to 320 Yuan From 175 Yuan

$SHA:688019

Research20d ago

Research Alert: Hdfc Bank Fy 26 Results: Merger Synergies Starting To Materialize

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FY 26 (Mar.) net profit, which rose 7.4% to INR760.3B led by loan growth, stronger other income, and cost efficiency, met our expectations. Loan growth picked up (+12%) and deposit base strengthened (+14.3%). While the loan-to-deposit ratio of 98.4% was still high and the deposit increase was led by term deposits, it reflects HDFC's steady progress at strengthening its deposit base to improve its liquidity position and reduce reliance on wholesale funding. We think HDFC's loan momentum will sustain, led by corporates and MSMEs. We see some pressure on NIM from increased mix of term deposits and the impact of a 25-bp cut in the benchmark repo rate in December 2025, but a structural shift in HDFC's funding base will keep its NIM in a stabilized range in FY 27. We expect better cost efficiency (on the benefits of technology/digital transformation) and stable asset quality (which will keep credit costs benign) will support profitability, with HDFC expecting ROA to sustain at FY 26's level of about 1.9% in FY 27.

$HDB

Research20d ago

Research Alert: Icici Bank: Broadly Better-than-expected Fy 26 Results

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:FY 26 (Mar.) EPADS rose 5.1% to INR149.54, beating our flattish estimate due to better-than-projected loan growth (+15.8%; of which, business banking: +24.4%; retail and corporate loans: +9% to +10%), NIM (stable at 4.32%), and non-banking income. We think robust demand from SMEs, the positive impact of the 0%-GST reform in September 2025 on consumer spending, and the strong housing market will sustain loan momentum into FY 27. We see some pressure on NIM from the 25-bp cut in the benchmark repo rate in December 2025, but expect ICICI's NIM to stay range-bound and industry leading, aided by faster growth in higher-yielding business loans and ICICI's relatively high mix of CASA deposits (at about 41.4% of total deposits at end-FY 26). Asset quality was solid. Provision charges rose 14.9% in FY 26 due to an additional standard asset provision set aside for agricultural priority sector credit facilities, but there is no change in the portfolio's asset quality. We expect provision charges to ease in FY 27.

$IBN

Research22d ago

Research Alert: CFRA Keeps Buy Rating On Shares Of Regions Financial Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:After digesting Q1 2026 earnings, we increase our 12-month target by $1 to $37, 12.5x our 2027 EPS estimate, a premium to RF's five-year forward P/E average of 9.7x, given an improving regulatory environment and exciting growth prospects. We raise our 2026 EPS estimate by $0.02 to $2.67 and increase 2027's by $0.07 to $2.95. We were a bit disappointed by Q1 results, as both net interest income and noninterest income contracted. However, RF is a well-run bank that successfully reduced costs, delivering positive operating leverage despite the weakness. Credit quality showed encouraging signs, and the bank's ROTCE of 18.3% remains superior to peers, many of whom do not expect to reach this level for at least three years. Significant upside remains. RF's CET1 ratio of 10.7% is conservative, in our view, coming in well above pre-pandemic levels. With proposed Basel III changes expected to reduce risk-weighted assets by 10%, RF is well positioned to return capital to shareholders at an accelerated rate.

$RF

Showing 2761-2780 of 3405